Pharmaceutical Quality System
ICH Q10 describes a model for an effective pharmaceutical quality system (PQS) that facilitates innovation and continual improvement throughout the product lifecycle — covering pharmaceutical development through product discontinuation.
What this does not cover
stated in the document's own scope- Describes a quality-system model that supplements GMP; it does not replace regional GMP requirements, which remain the binding baseline.
- Covers the pharmaceutical quality system, not the risk-management method it uses — that is ICH Q9.
- Covers the quality system, not the pharmaceutical development approach that feeds it, which is ICH Q8.
- Applies across the medicinal-product lifecycle; it is not a clinical-trial or pharmacovigilance quality standard.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
ICH Q10 describes a model for an effective pharmaceutical quality system (PQS) built on the ISO quality-management concepts, GMP, and the risk and development principles of ICH Q8 and Q9. It applies across the whole product lifecycle — pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation — and its stated objectives are to achieve product realisation, establish and maintain a state of control, and facilitate continual improvement. It sets out four elements a company should operate (process performance and product quality monitoring, corrective and preventive action, change management, and management review) and emphasises management responsibility and the use of knowledge management and QRM as enablers.
Scope & applicability
All pharmaceutical manufacturers. Describes elements of an effective PQS applicable across all stages of the product lifecycle.
Legal basis & how it acquires force
Q10 is an ICH Quality guideline, finalised at Step 4 in June 2008. An ICH guideline is not itself law; each region adopts it. The FDA issued Q10 as a guidance for industry; the EU implemented it within its GMP framework (its principles are reflected in EU GMP Part I, Chapter 1); and Japan gives it effect through MHLW. Q10 is explicit that it does not create new expectations beyond current regional GMP — it supplements GMP by describing a comprehensive quality-system model built on top of it.
Document structure
| Part | Covers |
|---|---|
| PQS objectives and enablers | Product realisation, state of control, continual improvement, and the knowledge-management and QRM enablers |
| Management responsibility | Leadership commitment, quality policy and planning, resources, and internal communication |
| Process performance and product quality monitoring | The system to monitor and maintain a state of control |
| Corrective action and preventive action (CAPA) | A structured CAPA system from investigation to effectiveness |
| Change management system | Evaluating, approving, and implementing changes using QRM |
| Management review and lifecycle application | Management review of performance and how the four elements apply across the lifecycle stages |
Key requirements
- Management responsibility — senior management commitment and periodic review
- Process Performance and Product Quality Monitoring System (PPQMS)
- CAPA system with effectiveness monitoring
- Change management process
- Knowledge management and information systems
- Quality metrics — defined KPIs monitored at site and management level
Implementation tips
- Management review agenda should include quality metrics, CAPA status, trend data — document the review outcomes and decisions
- CAPA effectiveness verification must have defined success criteria before the CAPA is closed
- Link your PQS to ICH Q10 section by section in your Quality Manual or equivalent document
Revision notes
Original version June 2008. Remains the foundational PQS reference. ICH Q12 (2019) extended lifecycle management concepts.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
Q10 completes the ICH quality trio: Q8 designs quality into the product, Q9 manages risk, and Q10 provides the quality system that operates both across the lifecycle. It is built on ISO quality-management principles and augments regional GMP rather than replacing it, and its lifecycle model connects forward to the change and lifecycle-management tools of ICH Q12.
ICH Q10: frequently asked questions
Quick answers to common questions about ICH Q10.
What are the four elements of the ICH Q10 pharmaceutical quality system?
Process performance and product quality monitoring; a corrective action and preventive action (CAPA) system; a change management system; and management review of process performance and product quality. Knowledge management and quality risk management are the enablers across all four.
Does ICH Q10 replace GMP?
No. Q10 is explicit that it supplements GMP and does not create expectations beyond current regional GMP. It describes a comprehensive quality-system model that operates on top of the binding GMP baseline.
How does Q10 relate to Q8 and Q9?
They are the ICH quality trio: Q8 builds quality into the product through design, Q9 supplies the risk-management method, and Q10 provides the pharmaceutical quality system that sustains both across the lifecycle.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.